Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Price:
3.09
USD
0.32%
Market Closed
Market Cap:
$790.1m
Income Statement
Earnings Waterfall
Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc
Income Statement
Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
24
|
32
|
30
|
22
|
19
|
15
|
20
|
30
|
32
|
41
|
46
|
45
|
50
|
52
|
48
|
44
|
38
|
32
|
|
| Revenue |
464
N/A
|
669
+44%
|
799
+19%
|
895
+12%
|
920
+3%
|
907
-1%
|
883
-3%
|
718
-19%
|
544
-24%
|
420
-23%
|
289
-31%
|
274
-5%
|
279
+2%
|
277
-1%
|
259
-6%
|
242
-7%
|
216
-11%
|
192
-11%
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
(93)
|
(125)
|
(141)
|
(151)
|
(150)
|
(156)
|
(169)
|
(163)
|
(169)
|
(167)
|
(149)
|
(153)
|
(148)
|
(149)
|
(151)
|
(152)
|
(153)
|
(152)
|
|
| Gross Profit |
372
N/A
|
544
+46%
|
659
+21%
|
745
+13%
|
770
+3%
|
750
-3%
|
714
-5%
|
555
-22%
|
376
-32%
|
253
-33%
|
140
-44%
|
121
-14%
|
130
+8%
|
128
-1%
|
108
-16%
|
90
-17%
|
63
-30%
|
40
-36%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(96)
|
(124)
|
(115)
|
(129)
|
(127)
|
(134)
|
(140)
|
(146)
|
(158)
|
(168)
|
(165)
|
(168)
|
(176)
|
(174)
|
(179)
|
(178)
|
(176)
|
(173)
|
|
| Selling, General & Administrative |
(86)
|
(111)
|
(100)
|
(108)
|
(112)
|
(118)
|
(129)
|
(133)
|
(140)
|
(148)
|
(151)
|
(152)
|
(158)
|
(159)
|
(159)
|
(160)
|
(157)
|
(153)
|
|
| Research & Development |
(4)
|
(6)
|
(9)
|
(16)
|
(19)
|
(22)
|
(16)
|
(18)
|
(18)
|
(17)
|
(15)
|
(18)
|
(19)
|
(19)
|
(19)
|
(19)
|
(19)
|
(18)
|
|
| Depreciation & Amortization |
(6)
|
(7)
|
(6)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
0
|
0
|
(3)
|
(1)
|
(1)
|
(2)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
8
|
8
|
8
|
8
|
2
|
(0)
|
3
|
0
|
2
|
5
|
2
|
2
|
1
|
0
|
|
| Operating Income |
276
N/A
|
420
+52%
|
543
+29%
|
616
+13%
|
643
+4%
|
616
-4%
|
574
-7%
|
409
-29%
|
217
-47%
|
85
-61%
|
(25)
N/A
|
(48)
-90%
|
(46)
+4%
|
(45)
+1%
|
(71)
-57%
|
(87)
-24%
|
(114)
-30%
|
(132)
-17%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(24)
|
(32)
|
(30)
|
(22)
|
(19)
|
(15)
|
(18)
|
(21)
|
(17)
|
(18)
|
(18)
|
(16)
|
(21)
|
(23)
|
(20)
|
(20)
|
(19)
|
(17)
|
|
| Non-Reccuring Items |
(8)
|
4
|
11
|
11
|
11
|
(0)
|
(0)
|
0
|
0
|
0
|
(6)
|
(5)
|
(5)
|
(159)
|
(168)
|
(182)
|
(212)
|
(65)
|
|
| Total Other Income |
6
|
9
|
6
|
3
|
2
|
(2)
|
(5)
|
(8)
|
(8)
|
(9)
|
668
|
669
|
668
|
669
|
(2)
|
(2)
|
(4)
|
(4)
|
|
| Pre-Tax Income |
250
N/A
|
401
+60%
|
531
+32%
|
608
+14%
|
637
+5%
|
599
-6%
|
552
-8%
|
380
-31%
|
192
-50%
|
57
-70%
|
618
+976%
|
600
-3%
|
596
-1%
|
441
-26%
|
(261)
N/A
|
(292)
-12%
|
(349)
-20%
|
(218)
+37%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
(26)
|
(44)
|
(62)
|
(68)
|
(75)
|
(70)
|
(61)
|
(38)
|
(18)
|
2
|
(756)
|
(760)
|
(759)
|
(764)
|
2
|
2
|
4
|
4
|
|
| Income from Continuing Operations |
225
|
357
|
469
|
540
|
562
|
530
|
491
|
343
|
174
|
59
|
(138)
|
(160)
|
(162)
|
(323)
|
(260)
|
(290)
|
(345)
|
(214)
|
|
| Income to Minority Interest |
(129)
|
(207)
|
(287)
|
(314)
|
(315)
|
(292)
|
(271)
|
(189)
|
(98)
|
(35)
|
19
|
29
|
30
|
98
|
115
|
127
|
150
|
93
|
|
| Net Income (Common) |
96
N/A
|
150
+56%
|
182
+22%
|
225
+24%
|
248
+10%
|
238
-4%
|
220
-7%
|
153
-30%
|
76
-51%
|
25
-68%
|
(119)
N/A
|
(131)
-10%
|
(132)
-1%
|
(225)
-70%
|
(145)
+36%
|
(163)
-12%
|
(195)
-20%
|
(121)
+38%
|
|
| EPS (Diluted) |
0.22
N/A
|
0.57
+159%
|
0.7
+23%
|
0.88
+26%
|
1.84
+109%
|
1.8
-2%
|
0.86
-52%
|
1.16
+35%
|
0.57
-51%
|
0.18
-68%
|
-0.9
N/A
|
-0.99
-10%
|
-0.97
+2%
|
-1.58
-63%
|
-1.05
+34%
|
-1.15
-10%
|
-1.37
-19%
|
-0.84
+39%
|
|
Switch to:
Switch to:
See Also
Discover More
